SECURITIES AND EXCHANGE COMMISSION
                                    
                          Washington, DC  20549
                                    
                                    
                                FORM 8-K
                                    
                                    
                                    
  CURRENT REPORT     
  
                            
                            
                            Pursuant to Se       ction 13 or 15(d) of the
  Securities Exc           hange Act of 1934
  
                            
                            
                            
                            July 21, 1994                    
  
                            
                            
                            
                            Mallinckrodt G               roup Inc.
  (Exact name of registrant as specified in its charter)
  
                                                       
  
  
     New York            1-483               36-1263901
  (State or other jurisdiction          (Commission             (IRS
  Employer
          of incorporation)                    File Number)       
        Identification No.)
  
  
  7733 Forsyth Boulevard, St. Louis, MO           63105-1820
  (Address of principal executive offices)              (Zip
  Code)
  
  
  Registrant's telephone number,                       (314)
  854-5200
           including area code
    
MALLINCKRODT ANNOUNCES DECISION
  OF VETERINARY COMPANY PRESIDENT TO RESIGN
  
  St. Louis, Missouri, July 21, 1994 -- Mallinckrodt Group Inc.
  (NYSE:MKG) announced today that William J. Mercer,  president
  and chief executive officer of its animal health business, has
  resigned from the company to pursue his career interests.  c.
  Ray Holman, president and chief executive officer of
  Mallinckrodt Group, will assume the additional role of
  Mallinckrodt Veterinary president until Mercer's successor is
  named.
  
  Holman said, "Bill Mercer wrote in his resignation letter that
  it is his personal desire to pursue a new, more challenging
  position outside the company.  He has made many contributions
  during his nearly 17 years with our company and we wish him a
  successful future.
  
  "The Mallinckrodt Veterinary management team is strong and I am
  confident the group will continue to work together to provide
  the leadership for a solid and profitable future," Holman said.
  
  In his resignation letter, Mercer stated, "With the closeness
  in our ages, time in our jobs, and the greater company needs, I
  want to take on a CEO successor, or CEO role, of a high quality
  company within the next year.  Since our timetables are not
  consistent, it is in the best interest of  both myself and the
  company that I obtain a position that better fits my long term
  career goals."
  
  Mercer was named president of Mallinckrodt Veterinary in
  December 1992, after holding a number of management positions
  at Mallinckrodt Medical,  primarily in medical imaging.  A
  restructuring program, including closing 11 plants, eliminating
  1,100 positions and rationalizing the product line, was
  initiated at the veterinary company in fiscal year 1993 and is
  contributing to improved earnings, according to Holman. 
  Operating earnings and margins were up approximately 50 percent
  for the first nine months of the year.
  
  Mallinckrodt Group Inc. is a Fortune 250 company with net sales
  of over $1.9 billion.  through its three technology-based
  businesses -- Mallinckrodt chemical and Mallinckrodt Medical,
  both headquartered in St. Louis, and Mallinckrodt Veterinary,
  headquartered in Mundelein, Ill. -- the company provides human
  and animal health products and specialty chemicals. 
  Mallinckrodt Group and its subsidiaries have approximately
  10,000 employees worldwide.